5
Clinical Trials associated with Desloratadine/Pseudoephedrine SulfateRandomized, Open-Label, 2-Way Crossover, Bioequivalence Study of Desloratadine and Pseudoephedrine 5 mg/240 mg Extended-Release Tablet and Clarinex-D® 24-Hour (Reference) Following a 5 mg/240 mg Dose in Healthy Subjects Under Fed Conditions
This is an open label, randomised, 2-way crossover, comparative bioequivalence study.
Randomized, Open-Label, 2-Way Crossover, Bioequivalence Study of Desloratadine and Pseudoephedrine 5 mg/240 mg Extended-Release Tablet and Clarinex-D® 24-Hour (Reference) Following a 5 mg/240 mg Dose in Healthy Subjects Under Fasting Conditions
This is an open label randomised, 2-way crossover, comparative bioequivalence study.
Evaluation of the Efficacy and Safety of Desloratadine Syrup in Children Suffering From Seasonal Allergic Rhinitis With or Without Intermittent Asthma
The purpose of this study was to test the effectiveness and safety of desloratadine (Aerius) syrup in children with hayfever with or without asthma. Patients took desloratadine syrup once a day for 28 days. Once a week, the doctor measured the patient's hayfever symptoms. The doctor also rated how much relief the patient got from treatment and recorded any side effects.
100 Clinical Results associated with Desloratadine/Pseudoephedrine Sulfate
100 Translational Medicine associated with Desloratadine/Pseudoephedrine Sulfate
100 Patents (Medical) associated with Desloratadine/Pseudoephedrine Sulfate
100 Deals associated with Desloratadine/Pseudoephedrine Sulfate